Item 2.02 Results of Operations and Financial Condition. OnJanuary 6, 2022 ,Biohaven Pharmaceutical Holding Company Ltd. (the "Company"), issued a press release announcing preliminary fourth quarter 2021 and full year 2021 net product revenue results for NURTEC ODT. The information in the press release reflects the Company's estimate with respect to net product revenue for NURTEC ODT based on currently available information which is preliminary and unaudited, is not a comprehensive statement of the Company's financial results for the fourth quarter of 2021 or full year 2021 and is subject to completion of the Company's financial closing procedures for the quarter. The Company's final results for the net product revenue for NURTEC ODT that will be issued upon completion of its closing procedures may vary from the preliminary estimate. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report and is incorporated herein by reference. In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02, and Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Registrant's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing. Special Note Regarding Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements relate to future events and involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may", "will", "should", "could", "would", "expects", "plans", "anticipates", "believes", "estimates", "projects", "predicts", "potential" and similar expressions intended to identify forward looking statements. These statements reflect the Company's current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent the Company's estimates and assumptions only as of the date of this Current Report on Form 8-K. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press Release, datedJanuary 6, 2022 issued byBiohaven Pharmaceutical Holding Company Ltd. 104 The cover page of this Current Report on Form 8-K formatted as Inline XBRL. 2
--------------------------------------------------------------------------------
© Edgar Online, source